Skip to Main Content
Facebook Visit us on LinkedIn Visit us on Twitter Visit us on YouTube Visit us on Instagram
Monee Hanna

Monee Hanna

Partner

Pacific Gateway
19191 South Vermont Avenue
Suite 900
Torrance, CA 90502
monee.hanna@nelsonmullins.com

Monee focuses her practice on the representation of pharmaceutical and medical device manufacturers in complex product liability litigation across the country. She also has experience in business litigation matters, including class actions, unfair competition claims, and antitrust actions.

Monee focuses her practice on the representation of pharmaceutical and medical device manufacturers in complex product liability litigation across the country. She also has experience in business litigation matters, including class actions, unfair competition claims, and antitrust actions.

Monee Hanna

Monee focuses her practice on the representation of pharmaceutical and medical device manufacturers in complex product liability litigation across the country. She also has experience in business litigation matters, including class actions, unfair competition claims, and antitrust actions.

Experience

Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.

  • Defended transdermal drug-delivery systems, diabetes medication, pelvic mesh, surgical devices, and cardiac medication actions in state and federal courts
  • Served as national counsel defending personal injury claims related to silicone gel and saline breast implants and tissue expanders
  • Obtained dismissal for medical device company in case involving alleged injuries from ruptured silicone gel breast implants (E.D. Mo. 2019), affirmed on appeal (8th Cir. 2021)
  • Obtained dismissals for medical device company on federal preemption under Riegel in four multi-plaintiff cases involving alleged injuries from ruptured silicone gel breast implants (C.D. Cal. 2019), affirmed on appeal (9th Cir. 2021)
  • Obtained dismissal for medical device company on federal preemption under Riegel in two-plaintiff case involving alleged injuries from ruptured silicone gel breast implants (D. Kan. 2019), affirmed on appeal (10th Cir. 2021)
  • Obtained dismissal for medical device company on federal preemption under Riegel and Connecticut Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (D.N.J. 2020)
  • Obtained dismissals for medical device company on federal preemption under Riegel in cases involving alleged injuries from silicone gel breast implants (N.D.N.Y. 2020, D. Md. 2020)
  • Obtained dismissal for medical device company on federal preemption under Riegel in cases involving alleged injuries from saline breast implants (S.D. Florida 2019, N.D. Ohio 2019)
  • Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (M.D. Fla. 2019)
  • Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (W.D. Wash. 2018)
  • Obtained dismissal for medical device company on federal preemption under Riegel and Ohio Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (N.J. Sup. Ct. Law Div. Middlesex Cty 2018)
  • Obtained summary judgment for medical device company on federal preemption under Riegel and for lack of defect or causation in case involving alleged mold toxicity from saline breast implants, following exclusion of plaintiff’s three experts under Daubert (C.D. Cal. 2017), affirmed on appeal (9th Cir. 2019)
  • Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries allegedly caused by ruptured silicone gel breast implant (D.S.C. 2014)
  • Obtained summary judgment for medical device company for lack of defect in case involving injuries allegedly caused by leaking tissue expander (N.J. Super. Ct. Law Div. Atlantic Cty 2014)
  • Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries caused by ruptured saline breast implant (E.D. Cal. 2012)
  • Obtained dismissal for medical device company on federal preemption under Riegel in case involving Class III stair-climbing wheelchair (E.D. Cal. 2011)

Education

  • Harvard Law School, JD (2008)
    • Harvard Civil Rights-Civil Liberties Law Review, General Editor
  • University of California Los Angeles, BA, cum laude (2005)
    • Phi Beta Kappa

Admissions

  • California
  • U.S. District Court for the Central District of California
  • U.S. District Court for the Eastern District of California
  • U.S. District Court for the Northern District of California
  • U.S. District Court for the Southern District of California

Practice Areas

  • Legal Aid Foundation of Los Angeles Associate Advisory Board (2014-present; Board secretary 2020-2022)
  • Pro bono attorney, Alliance for Children’s Rights (2012-present)